Anagenics reaches near break-even cash flow after restructuring

Restructuring drives sharp cash-flow improvement

Anagenics Limited (ASX:AN1) has reduced its operating cash outflow to A$10,000 in the three months to 30 September, down from A$300,000 in the same quarter a year earlier. The company attributed the A$290,000 improvement to the restructuring of its business operations, and said it is now trading profitably.

The latest result extends a turnaround thread that has already included 3Q26 cash-flow improvement, when Anagenics reported narrowing outflows after restructuring. The new filing does not provide a net profit figure, margin data or a detailed bridge showing how the company reached its claim of profitable trading, so the strength and durability of that position will need to be tested in subsequent financial reports.

YSB royalties remain the main cash contributor

Royalty income from the YSB product line provided a substantial part of the quarter’s cash activity. Anagenics received A$446,000 during 1Q27 for revenue invoiced in June, while it invoiced a further A$377,000 for the three months to September. That second amount was expected to be received in October and was therefore not yet in the quarter-end cash balance.

The company said it expects to generate operating cash flow going forward and continues to search for value-accretive opportunities consistent with its stated strategy. That outlook is forward-looking: the reported quarter still recorded net operating cash usage of A$10,000, even as customer receipts reached A$1.381 million and operating payments totalled A$1.391 million.

Cash balance holds above half a million dollars

Anagenics finished the quarter with A$532,000 in cash and cash equivalents, comprising A$390,000 in bank balances and A$142,000 in call deposits. The balance was reduced by A$33,000 in debt repayments and a further A$2,000 exchange-rate movement, with no investing inflows or outflows recorded.

The quarter included A$31,000 in directors’ fees. With no financing facilities listed as available or drawn at quarter-end, the company’s cash position remains closely tied to the conversion of royalty invoices and the continuation of its lower-cost operating model. The next report should show whether the A$377,000 YSB invoice was collected and whether operating cash flow has moved decisively into positive territory.